Arcadia Biosciences (RKDA) Announces CFO Transition
"On behalf of Arcadia, I would like to thank Pam for her many contributions over the past 17 years," said Board of Directors Chairman
Schaefer is an accomplished finance executive with more than 20 years of experience in investments and corporate finance. He began his career as an equity research analyst and later joined a Fortune 500 company where he helped lead several acquisitions and divestitures. In 2013, Schaefer moved into consumer products where he led teams, developed long-range strategies and helped launch new products across a variety of industries including vitamins and apparel. He later served as director of finance at Flavor Producers, a portfolio company owned by private equity firm GTCR that specialized in beverages and snacks, before joining Arcadia in 2020.
Schaefer earned a bachelor of business administration in economics and finance from
"T.J. has played a lead role in the commercial launch of GoodWheat™ as well as the development of our long-term strategy known as Project Greenfield," said
"Arcadia is in the early stage of commercial product launch with many exciting opportunities on the horizon," said Schaefer. "I look forward to working closely with the team to make these products successful."
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the transition of the CFO position, the success of the company's long-term strategy and the growth of the company's brands. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to, the risks set forth in Arcadia's Annual Report on Form 10-K for the year ended
View original content to download multimedia:https://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-announces-cfo-transition-301690717.html
Arcadia Biosciences, Sue Wandell, email@example.com